Publications

1. Joseph R, Robinson ML, Lambert L, Srivastava OP. Lens-specific betaA3/A1-conditional knockout mice: Phenotypic characteristics and calpain activation causing protein degradation and insolubilization. PLoS One. 2023; 18 (3):e0281386 Epub 2023 Mar 29
   View PubMed
2. Leier A, Moore M, Liu H, Daniel M, Hyde AM, Messiaen L, Korf BR, Selvakumaran J, Ciszewski L, Lambert L, Foote J, Wallace MR, Kesterson RA, Dickson G, Popplewell L, Wallis D. Targeted exon skipping of NF1 exon 17 as a therapeutic for neurofibromatosis type I. Mol Ther Nucleic Acids. 2022 Jun 14; 28:261-278 Epub 2022 Mar 15
   View PubMed
3. Awad EK, Moore M, Liu H, Ciszewski L, Lambert L, Korf BR, Popplewell L, Kesterson RA, Wallis D. Restoration of Normal NF1 Function with Antisense Morpholino Treatment of Recurrent Pathogenic Patient-Specific Variant c.1466A>G; p.Y489C. J Pers Med. 2021 Dec 7; 11 (12) Epub 2021 Dec 07
   View PubMed
4. Voskobiynyk Y, Battu G, Felker SA, Cochran JN, Newton MP, Lambert LJ, Kesterson RA, Myers RM, Cooper GM, Roberson ED, Barsh GS. Aberrant regulation of a poison exon caused by a non-coding variant in a mouse model of Scn1a-associated epileptic encephalopathy. PLoS Genet. 2021 Jan; 17 (1):e1009195 Epub 2021 Jan 07
   View PubMed
5. Wallis D, Ke H, Tuner AN, Lambert LJ, Yoder BS, Moore JF, Sharer JD, Yang K, Yang Q@, Johnson MS, Smith DL, Nagy TR, Brosius SN, Schoeb TR, Bradley K, Huang F, Korf BR, Anastasaki C, Gutmann DH, Kesterson RA. GABAergic and Systemic Deletion of Neurofibromin Induces Complex Metabolic and Behavioral Phenotypes Cell Metabolism. 2021.
   
6. Lambert LJ, Johnson LW, Kennedy D, Cadillac J, Kesterson RA. Improved Oviduct Transfer Surgery for Genetically Modified Rat Production. Bio Protoc. 2017 Aug 20; 7 (16)
   View PubMed
7. Kesterson RA, Johnson LW, Lambert LJ, Vivian JL, Welch DR, Ballinger SW. Generation of Mitochondrial-nuclear eXchange Mice via Pronuclear Transfer. Bio Protoc. 2016 Oct 20; 6 (20)
   View PubMed
8. Lambert LJ, Challa AK, Niu A, Zhou L, Tucholski J, Johnson MS, Nagy TR, Eberhardt AW, Estep PN, Kesterson RA, Grams JM. Increased trabecular bone and improved biomechanics in an osteocalcin-null rat model created by CRISPR/Cas9 technology. Dis Model Mech. 2016 Oct 1; 9 (10):1169-1179 Epub 2016 July 28
   View PubMed
9. Xue X, Mutyam V, Tang L, Biswas S, Du M, Jackson LA, Dai Y, Belakhov V, Shalev M, Chen F, Schacht J, J Bridges R, Baasov T, Hong J, Bedwell DM, Rowe SM. Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftor. Am J Respir Cell Mol Biol. 2014 Apr; 50 (4):805-16
   View PubMed